Aarti Pharmalabs Ltd reports Q2 FY27 standalone revenue of ₹6,126 million, up 46.8% year on year
- Revenue rose 14.6% sequentially.
- EBITDA margin was 22.17%, down 265 bps sequentially and up 441 bps year on year.
- Net profit was ₹658 million, down 7.7% sequentially and up 180.0% year on year; the quarter included a ₹20 million exceptional loss.